Skip to main content
. Author manuscript; available in PMC: 2020 Feb 24.
Published in final edited form as: Br J Psychiatry. 2019 Feb 26:1–7. doi: 10.1192/bjp.2019.30

Table 2. Psychotropic medication usage amongst participants with ASD.

Reported psychotropic medication usage in participants with ASD based on NCMH questionnaire response fields. N - number of individuals reporting usage of medication of this type; % - percentage of total who responded.

Reported lifetime use (n)
Stimulants 6 (6.3%)
Antidepressants 74 (78.7%)
Anxiolytics 29 (31.2%)
Hypnotics 17 (18.1%)
Mood Stabilisers 6 (6.5%)
Antipsychotics 25 (26.3%)